FONT-SIZE Plus   Neg

Nucor Expects Q3 EPS Of $0.35 - $0.40 - Quick Facts

Nucor Corporation(NUE), a manufacturer of steel products, Tuesday said it expects its third-quarter earnings to be in range of $0.35 to $0.40 per share, an increase from $0.35 per share reported during the corresponding quarter last year. This year's projected results include an $18 million LIFO credit, compared with $84 million a year ago. Last year results also included a non-cash charge of $28.2 million, the company said. Analysts expect the company to report earnings of $0.38 per share. Analysts' estimates typically exclude one-time items.

The company said the overall operating performance in the steel mills segment has improved, and sheet steel profitability improved as a result of competitor supply disruptions, customer inventory restocking and some market demand improvement. Structural steel results improved due to Nucor Yamato Steel's higher production, the company added. The company's raw materials segment is expected to report weaker results in the third quarter, mainly due to increased start-up costs at its plant in Louisiana, whose production is expected to begin soon.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade NUE now with 
Follow RTT